Activation of the renin-angiotensin system within podocytes in diabetes. (Q48241272)

9 February 2018

title

Activation of the renin-angiotensin system within podocytes in diabetes. (English)

1 reference

9 February 2018

author

Dong-Ryeol Ryu

6

1 reference

9 February 2018

Jong Eun Lee

11

1 reference

9 February 2018

author name string

Yoo TH

1

1 reference

9 February 2018

Li JJ

2

1 reference

9 February 2018

Kim JJ

3

1 reference

9 February 2018

Jung DS

4

1 reference

9 February 2018

Kwak SJ

5

1 reference

9 February 2018

Choi HY

7

1 reference

9 February 2018

Kim JS

8

1 reference

9 February 2018

Kim HJ

9

1 reference

9 February 2018

Han SH

10

1 reference

9 February 2018

Han DS

12

1 reference

9 February 2018

Kang SW

13

1 reference

9 February 2018

language of work or name

English

0 references

publication date

14 March 2007

1 reference

9 February 2018

published in

Kidney International

1 reference

9 February 2018

volume

71

1 reference

9 February 2018

issue

10

1 reference

9 February 2018

page(s)

1019-1027

1 reference

9 February 2018

https://scigraph.springernature.com/pub.10.1038/sj.ki.5002195

exact match

0 references

cites work

The stages in diabetic renal disease. With emphasis on the stage of incipient diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002195

7 January 2021

Role of angiotensin II in diabetic nephropathy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002195

7 January 2021

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002195

7 January 2021

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002195

7 January 2021

ACE-inhibitors but not endothelin receptor blockers prevent podocyte loss in early diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002195

7 January 2021

Podocyte biology and the emerging understanding of podocyte diseases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002195

7 January 2021

Angiotensin II receptor blocker inhibits p27Kip1 expression in glucose-stimulated podocytes and in diabetic glomeruli

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002195

7 January 2021

Proteinuria and the expression of the podocyte slit diaphragm protein, nephrin, in diabetic nephropathy: effects of angiotensin converting enzyme inhibition

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002195

7 January 2021

Podocyte foot process broadening in experimental diabetic nephropathy: amelioration with renin-angiotensin blockade

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002195

7 January 2021

The renin-angiotensin system and progression of renal disease: from hemodynamics to cell biology

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002195

7 January 2021

The role of angiotensin II in diabetic nephropathy: emphasis on nonhemodynamic mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002195

7 January 2021

Mechanism of increased angiotensin II levels in glomerular mesangial cells cultured in high glucose

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002195

7 January 2021

High glucose concentration stimulates intracellular renin activity and angiotensin II generation in rat mesangial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002195

7 January 2021

Activation of a local tissue angiotensin system in podocytes by mechanical strain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002195

7 January 2021

A quantitative immunofluorescence study of glomerular cell adhesion proteins in proteinuric states

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002195

7 January 2021

P-Cadherin is decreased in diabetic glomeruli and in glucose-stimulated podocytes in vivo and in vitro studies.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002195

7 January 2021

Glomerular cell number in normal subjects and in type 1 diabetic patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002195

7 January 2021

Podocyte loss and progressive glomerular injury in type II diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002195

7 January 2021

Podocyte number in normotensive type 1 diabetic patients with albuminuria

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002195

7 January 2021

Urinary excretion of podocytes in patients with diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002195

7 January 2021

Nephrin expression is reduced in human diabetic nephropathy: evidence for a distinct role for glycated albumin and angiotensin II.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002195

7 January 2021

Irbesartan normalises the deficiency in glomerular nephrin expression in a model of diabetes and hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002195

7 January 2021

AT(1) and AT(2) receptors in the kidney: role in disease and treatment.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002195

7 January 2021

A novel mechanism for angiotensin II formation in streptozotocin-diabetic rat glomeruli

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002195

7 January 2021

Chymase is upregulated in diabetic nephropathy: implications for an alternative pathway of angiotensin II-mediated diabetic renal and vascular disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002195

7 January 2021

Effect of glucose on the expression of the angiotensinogen gene in opossum kidney cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002195

7 January 2021

Characterization of angiotensin II-receptor subtypes in podocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002195

7 January 2021

Functional expression of the renin-angiotensin system in human podocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002195

7 January 2021

Angiotensin II type 1 receptor overexpression in podocytes induces glomerulosclerosis in transgenic rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002195

7 January 2021

Angiotensin II modulates cellular functions of podocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002195

7 January 2021

Permselective dysfunction of podocyte-podocyte contact upon angiotensin II unravels the molecular target for renoprotective intervention

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002195

7 January 2021

Interactions between angiotensin II and NF-kappaB-dependent pathways in modulating macrophage infiltration in experimental diabetic nephropathy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002195

7 January 2021

ANG II type 2 receptor regulates smooth muscle growth and force generation in late fetal mouse development

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002195

7 January 2021

Update on the role of the AT2 receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002195

7 January 2021

Hypoxia and high glucose upregulate AT1 receptor expression and potentiate ANG II-induced proliferation in VSM cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002195

7 January 2021

Additive effect of ACE inhibition and angiotensin II receptor blockade in type I diabetic patients with diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002195

7 January 2021

Renoprotective effects of adding angiotensin II receptor blocker to maximal recommended doses of ACE inhibitor in diabetic nephropathy: a randomized double-blind crossover trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002195

7 January 2021

Protein kinase C is activated in glomeruli from streptozotocin diabetic rats. Possible mediation by glucose

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002195

7 January 2021

Role for protein kinase C in the mediation of increased fibronectin accumulation by mesangial cells grown in high-glucose medium

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002195

7 January 2021

Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002195

7 January 2021

Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002195

7 January 2021

Role of angiotensin II in glucose-induced inhibition of mesangial matrix degradation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002195

7 January 2021

Role of 12-lipoxygenase in the stimulation of p38 mitogen-activated protein kinase and collagen alpha5(IV) in experimental diabetic nephropathy and in glucose-stimulated podocytes.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002195

7 January 2021

Identifiers

DOI

10.1038/SJ.KI.5002195

1 reference

9 February 2018

release_c5xdosvdajg2nbbci47zzh5skq

Fatcat ID

0 references

PubMed ID

17361112

1 reference

9 February 2018